Cargando…
Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy
PURPOSE: This study evaluates the benefit of a virtual bolus method for volumetric modulated arc therapy (VMAT) plan optimization to compensate breast modifications that may occur during breast treatment. METHODS: Ten files were replanned with VMAT giving 50 Gy to the breast and 47 Gy to the nodes w...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123145/ https://www.ncbi.nlm.nih.gov/pubmed/29959819 http://dx.doi.org/10.1002/acm2.12398 |
_version_ | 1783352798752014336 |
---|---|
author | Tyran, Marguerite Tallet, Agnes Resbeut, Michel Ferre, Marjorie Favrel, Veronique Fau, Pierre Moureau‐Zabotto, Laurence Darreon, Julien Gonzague, Laurence Benkemouche, Ahcene Varela‐Cagetti, Leonel Salem, Naji Farnault, Bertrand Acquaviva, Marie‐Aimee Mailleux, Hugues |
author_facet | Tyran, Marguerite Tallet, Agnes Resbeut, Michel Ferre, Marjorie Favrel, Veronique Fau, Pierre Moureau‐Zabotto, Laurence Darreon, Julien Gonzague, Laurence Benkemouche, Ahcene Varela‐Cagetti, Leonel Salem, Naji Farnault, Bertrand Acquaviva, Marie‐Aimee Mailleux, Hugues |
author_sort | Tyran, Marguerite |
collection | PubMed |
description | PURPOSE: This study evaluates the benefit of a virtual bolus method for volumetric modulated arc therapy (VMAT) plan optimization to compensate breast modifications that may occur during breast treatment. METHODS: Ten files were replanned with VMAT giving 50 Gy to the breast and 47 Gy to the nodes within 25 fractions. The planning process used a virtual bolus for the first optimization, then the monitors units were reoptimized without bolus, after fixing the segments shapes. Structures and treatment planning were exported on a second scanner (CT) performed during treatment as a consequence to modifications in patient's anatomy. The comparative end‐point was clinical target volume's coverage. The first analysis compared the VMAT plans made using the virtual bolus method (VB‐VMAT) to the plans without using it (NoVB‐VMAT) on the first simulation CT. Then, the same analysis was performed on the second CT. Finally, the level of degradation of target volume coverage between the two CT using VB‐VMAT was compared to results using a standard technique of forward‐planned multisegment technique (Tan‐IMRT). RESULTS: Using a virtual bolus for VMAT does not degrade dosimetric results on the first CT. No significant result in favor of the NoVB‐VMAT plans was noted. The VB‐VMAT method led to significant better dose distribution on a second CT with modified anatomies compared to NoVB‐VMAT. The clinical target volume's coverage by 95% (V95%) of the prescribed dose was 98.9% [96.1–99.6] on the second CT for VB‐VMAT compared to 92.6% [85.2–97.7] for NoVB‐VMAT (P = 0.0002). The degradation of the target volume coverage for VB‐VMAT is not worse than for Tan‐IMRT: the median differential of V95% between the two CT was 0.9% for VMAT and 0.7% for Tan‐IMRT (P = 1). CONCLUSION: This study confirms the safety and benefit of using a virtual bolus during the VMAT planning process to compensate potential breast shape modifications. |
format | Online Article Text |
id | pubmed-6123145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61231452018-09-10 Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy Tyran, Marguerite Tallet, Agnes Resbeut, Michel Ferre, Marjorie Favrel, Veronique Fau, Pierre Moureau‐Zabotto, Laurence Darreon, Julien Gonzague, Laurence Benkemouche, Ahcene Varela‐Cagetti, Leonel Salem, Naji Farnault, Bertrand Acquaviva, Marie‐Aimee Mailleux, Hugues J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: This study evaluates the benefit of a virtual bolus method for volumetric modulated arc therapy (VMAT) plan optimization to compensate breast modifications that may occur during breast treatment. METHODS: Ten files were replanned with VMAT giving 50 Gy to the breast and 47 Gy to the nodes within 25 fractions. The planning process used a virtual bolus for the first optimization, then the monitors units were reoptimized without bolus, after fixing the segments shapes. Structures and treatment planning were exported on a second scanner (CT) performed during treatment as a consequence to modifications in patient's anatomy. The comparative end‐point was clinical target volume's coverage. The first analysis compared the VMAT plans made using the virtual bolus method (VB‐VMAT) to the plans without using it (NoVB‐VMAT) on the first simulation CT. Then, the same analysis was performed on the second CT. Finally, the level of degradation of target volume coverage between the two CT using VB‐VMAT was compared to results using a standard technique of forward‐planned multisegment technique (Tan‐IMRT). RESULTS: Using a virtual bolus for VMAT does not degrade dosimetric results on the first CT. No significant result in favor of the NoVB‐VMAT plans was noted. The VB‐VMAT method led to significant better dose distribution on a second CT with modified anatomies compared to NoVB‐VMAT. The clinical target volume's coverage by 95% (V95%) of the prescribed dose was 98.9% [96.1–99.6] on the second CT for VB‐VMAT compared to 92.6% [85.2–97.7] for NoVB‐VMAT (P = 0.0002). The degradation of the target volume coverage for VB‐VMAT is not worse than for Tan‐IMRT: the median differential of V95% between the two CT was 0.9% for VMAT and 0.7% for Tan‐IMRT (P = 1). CONCLUSION: This study confirms the safety and benefit of using a virtual bolus during the VMAT planning process to compensate potential breast shape modifications. John Wiley and Sons Inc. 2018-06-30 /pmc/articles/PMC6123145/ /pubmed/29959819 http://dx.doi.org/10.1002/acm2.12398 Text en © 2018 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Tyran, Marguerite Tallet, Agnes Resbeut, Michel Ferre, Marjorie Favrel, Veronique Fau, Pierre Moureau‐Zabotto, Laurence Darreon, Julien Gonzague, Laurence Benkemouche, Ahcene Varela‐Cagetti, Leonel Salem, Naji Farnault, Bertrand Acquaviva, Marie‐Aimee Mailleux, Hugues Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy |
title | Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy |
title_full | Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy |
title_fullStr | Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy |
title_full_unstemmed | Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy |
title_short | Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy |
title_sort | safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123145/ https://www.ncbi.nlm.nih.gov/pubmed/29959819 http://dx.doi.org/10.1002/acm2.12398 |
work_keys_str_mv | AT tyranmarguerite safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT talletagnes safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT resbeutmichel safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT ferremarjorie safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT favrelveronique safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT faupierre safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT moureauzabottolaurence safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT darreonjulien safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT gonzaguelaurence safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT benkemoucheahcene safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT varelacagettileonel safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT salemnaji safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT farnaultbertrand safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT acquavivamarieaimee safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy AT mailleuxhugues safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy |